Liquidia (LQDA) Cash from Investing Activities (QoQ) (2020 - 2026)
Liquidia (LQDA) Cash from Investing Activities (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Liquidia | 7.47 Bn | 7.25 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.92% |
| Dec 31, 2025 | -343.25% |
| Sep 30, 2025 | 13.81% |
| Jun 30, 2025 | -220.30% |
| Mar 31, 2025 | 93.10% |
| Dec 31, 2024 | -173.61% |
| Sep 30, 2024 | -35.43% |
| Jun 30, 2024 | -106.73% |
| Mar 31, 2024 | -202.91% |
| Dec 31, 2023 | 98.03% |
| Sep 30, 2023 | -4,210.70% |
| Jun 30, 2023 | 33.24% |
| Mar 31, 2023 | 25.87% |
| Dec 31, 2022 | -422.34% |
| Sep 30, 2022 | -4,600.00% |
| Jun 30, 2021 | 32.69% |
| Mar 31, 2021 | -105.41% |
| Dec 31, 2020 | 884.51% |
| Sep 30, 2020 | 70.00% |
| Jun 30, 2020 | -124.13% |